Compare Nuwellis Inc (NUWE) vs Valero Energy Corporation (VLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Nuwellis Inc vs Valero Energy Corporation — how do they compare? Nuwellis Inc trades at $0.68 (market cap $2.20M), while Valero Energy Corporation trades at $443.1 (market cap $122.11B). The key difference: Valero Energy Corporation is far larger — about 55504.5× Nuwellis Inc's market cap, and Valero Energy Corporation pays a 1.13% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nuwellis Inc for 26 Days and Valero Energy Corporation for 56 Days on average.
| NUWE | VLO | |
|---|---|---|
Market Cap | $2.20M | $122.11B |
Volume | 121,544 | 1,826,747 |
Sector | Health | Energy |
52-Week High | $146.65 | $443.80 |
52-Week Low | $0.68 | $156.39 |
Typical Hold Time | 26 Days | 56 Days |
Enterprise Value | -$1.52M | $125.59B |
Dividend Yield | — | 1.13% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Valero Energy (VLO) trades at $443.80, up 5.86% today and near its 52-week high, supported by bullish technical signals and strong earnings beats. Recent quarters have exceeded EPS expectations, with Q2 2026 EPS of $12.54 beating the $10.11 forecast. The stock shows robust profitability with a 29.31% ROE and trades at a P/E of 17.69, below the sector average. Positive news flow highlights refining margin strength and institutional interest.
The outlook remains positive given earnings momentum and favorable analyst sentiment, though risks include potential diesel export policy changes and volatile energy markets. Revenue is projected to rebound to $139.4B in 2026, driving net income higher. Investors should weigh solid fundamentals against sector-specific headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →About Valero Energy Corporation
Valero Energy is one of the largest independent refiners in the United States. It operates 14 refineries with a total throughput capacity of 3.2 million barrels a day in the United States, Canada, and the United Kingdom. Valero also owns 14 ethanol plants with capacity of 1.7 billion gallons of ethanol a year and holds a 50% stake in Diamond Green Diesel, which has capacity to produce 700 million gallons per year of renewable diesel.
Read more on VLO →
